itinai content

  • AI News
  • AI Sales
  • Apple AI
  • Biohacking
  • Clinical Trials
  • Compare
  • Computer Vision
  • DeepSense
  • farma
  • Instruments
  • Management
  • Marketing
  • Marktechpost
  • Open AI
  • resume
  • КП
  • OpenBMB Just Released MiniCPM-o 2.6: A New 8B Parameters, Any-to-Any Multimodal Model that can Understand Vision, Speech, and Language and Runs on Edge Devices

    14 января, 2025

    Artificial intelligence has made significant strides in recent years, but challenges remAIn in balancing computational efficiency and versatility. State-of-the-art multimodal models, such as GPT-4, often require substantial computational resources, limiting their use to high-end servers. This creates accessibility barriers and leaves edge devices like smartphones and tablets unable to leverage such technologies effectively. Additionally, real-time… →

    AI News, Marktechpost
    AI, AI Business, AI Education, AI Healthcare, AI Help, AI in Finance, AI Libs, AI Marketing, AI Product, AI Research, AI Sales, AI Staff, AI Startup, AI Tech, AI UX, Automation, Edge AI, Explainable AI, Natural Language Processing, NLP, No-code AI, Open Source AI, Quantization, Transform AI, XAI
  • Meet VideoRAG: A Retrieval-Augmented Generation (RAG) Framework Leveraging Video Content for Enhanced Query Responses

    14 января, 2025

    Video-based technologies have become essential tools for information retrieval and understanding complex concepts. Videos combine visual, temporal, and contextual data, providing a multimodal representation that surpasses static images and text. With the increasing popularity of video-sharing platforms and the vast repository of educational and informational videos available online, leveraging videos as knowledge sources offers unprecedented… →

    AI News, Marktechpost
    AI, AI Business, AI Education, AI Healthcare, AI Help, AI in Finance, AI Libs, AI Marketing, AI Product, AI Research, AI Sales, AI Staff, AI Startup, AI Tech, AI UX, Automation, Edge AI, Explainable AI, Natural Language Processing, NLP, No-code AI, Open Source AI, Quantization, Transform AI, XAI
  • Outcome-Refining Process Supervision: Advancing Code Generation with Structured Reasoning and Execution Feedback

    14 января, 2025

    LLMs excel in code generation but struggle with complex programming tasks requiring deep algorithmic reasoning and intricate logic. Traditional outcome supervision approaches, which guide final output quality models, are limited in addressing these challenges. Process supervision using Process Reward Models (PRMs) has shown promise by focusing on reasoning steps, but it demands extensive annotated data… →

    AI News, Marktechpost
    AI, AI Business, AI Education, AI Healthcare, AI Help, AI in Finance, AI Libs, AI Marketing, AI Product, AI Research, AI Sales, AI Staff, AI Startup, AI Tech, AI UX, Automation, Edge AI, Explainable AI, Natural Language Processing, NLP, No-code AI, Open Source AI, Quantization, Transform AI, XAI
  • Effectiveness of potent topical corticosteroids versus mild ones in primary care for children with moderate flare-ups of atopic dermatitis; results of a randomised controlled trial

    14 января, 2025

    CONCLUSION: Despite the small sample size, the data suggests a clinical benefit from starting with a potent TCS rather than a mild TCS when a flare-up of AD is moderate. →

    Clinical Trials
  • Study protocol for Adaptive ChemoTherapy for Ovarian cancer (ACTOv): a multicentre phase II randomised controlled trial to evaluate the efficacy of adaptive therapy (AT) with carboplatin, based on changes in CA125, in patients with relapsed platinum-sensitive high-grade serous or high-grade endometrioid ovarian cancer

    14 января, 2025

    INTRODUCTION: Adaptive ChemoTherapy for Ovarian cancer (ACTOv) is a phase II, multicentre, randomised controlled trial, evaluating an adaptive therapy (AT) regimen with carboplatin in women with relapsed, platinum-sensitive high-grade serous or high-grade endometrioid cancer of the ovary, fallopian tube and peritoneum whose disease has progressed at least 6 months after day 1 of the last… →

    Clinical Trials
  • Cost-effectiveness of metacognitive therapy for cardiac rehabilitation participants with symptoms of anxiety and/or depression: analysis of a randomised controlled trial

    14 января, 2025

    CONCLUSIONS: Results suggest that intervention may be cost-saving and health-increasing; however, findings are uncertain and subject to limitations. Further research should aim to reduce the uncertainty in the findings (eg, with larger sample sizes) and explore potential longer-term economic benefits associated with MCT in this setting. →

    Clinical Trials
  • Improving the accUracy of Referrals to the emerGency departmEnt of patieNts with chesT pain using the modified HEART score in Emergency Medical Transport (URGENT 2.0): protocol for a multicentre randomised controlled trial

    14 января, 2025

    INTRODUCTION: Ischaemic heart disease is the single most common cause of death worldwide. Traditionally, distinguishing patients with cardiac ischaemia from patients with less alarming disease, in prehospital triage of chest pain, is challenging for both general practitioners and ambulance paramedics. Less than 20% of patients with chest pain, transferred to the emergency department (ED), have… →

    Clinical Trials
  • Impact of alternative diagnostic labels for melanoma in situ on management choices and psychological outcomes: protocol for an online randomised study

    14 января, 2025

    INTRODUCTION: A diagnosis of melanoma in situ presents negligible risk to a person’s lifespan or physical well-being, but existing terminology makes it difficult for patients to distinguish these from higher risk invasive melanomas. This study aims to explore whether using an alternative label for melanoma in situ may influence patients’ management choices and anxiety levels. →

    Clinical Trials
  • Randomised, placebo-controlled, double-blinded, four-way crossover trial to demonstrate the comparative pharmacodynamic equivalence of a non-invasive diagnostic test for adrenal insufficiency in a healthy population: the STARLIT-2 study protocol

    14 января, 2025

    INTRODUCTION: Cortisol is an essential stress hormone and failure of its production, known as adrenal insufficiency (AI), is associated with significant mortality due to adrenal crisis. The Short Synacthen Test (SST) is the current diagnostic test of choice for AI, but it is both invasive and resource intensive. Globally, there is an unmet need for… →

    Clinical Trials
  • A phase II double-blind multicentre, placebo-controlled trial to assess the efficacy and safety of alpelisib (BYL719) in paediatric and adult patients with Megalencephaly-CApillary malformation Polymicrogyria syndrome (MCAP): the SESAM study protocol

    14 января, 2025

    INTRODUCTION: The megalencephaly capillary malformation polymicrogyria (MCAP syndrome) results from mosaic gain-of-function PIK3CA variants. The main clinical features are macrocephaly, somatic overgrowth, neurodevelopmental delay and brain anomalies. Alpelisib (Vijoice) is a recently FDA-approved PI3Kα-specific inhibitor for patients with PIK3CA-related overgrowth spectrum (PROS). During its development, in patients with the MCAP subgroup of PROS, there was… →

    Clinical Trials
Предыдущая страница
1 … 283 284 285 286 287 … 711
Следующая страница